72 related articles for article (PubMed ID: 26556626)
1. Peptidomimetic suppresses proliferation and invasion of gastric cancer cells by fibroblast growth factor 2 signaling cascade blockage.
Li W; Du X; Chen Q; Kang Y; Xu C; Fan L; Ye H; Ying S; Shi L; Jin R; Wu J; Liang G; Li X
Anticancer Drugs; 2016 Mar; 27(3):164-72. PubMed ID: 26556626
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic potential of a novel non-ATP-competitive fibroblast growth factor receptor 1 inhibitor on gastric cancer.
Xu C; Li W; Qiu P; Xia Y; Du X; Wang F; Shen L; Chen Q; Zhao Y; Jin R; Wu J; Liang G; Li X
Anticancer Drugs; 2015 Apr; 26(4):379-87. PubMed ID: 25521558
[TBL] [Abstract][Full Text] [Related]
3. A peptide derivative serves as a fibroblast growth factor 2 antagonist in human gastric cancer.
Fan L; Li W; Ying S; Shi L; Wang Z; Chen G; Ye H; Wu X; Wu J; Liang G; Li X
Tumour Biol; 2015 Sep; 36(9):7233-41. PubMed ID: 25894376
[TBL] [Abstract][Full Text] [Related]
4. The FGF2-binding peptide P7 inhibits melanoma growth in vitro and in vivo.
Yu Y; Gao S; Li Q; Wang C; Lai X; Chen X; Wang R; Di J; Li T; Wang W; Wu X
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1321-8. PubMed ID: 22481251
[TBL] [Abstract][Full Text] [Related]
5. The nucleotide analog cidofovir suppresses basic fibroblast growth factor (FGF2) expression and signaling and induces apoptosis in FGF2-overexpressing endothelial cells.
Liekens S; Gijsbers S; Vanstreels E; Daelemans D; De Clercq E; Hatse S
Mol Pharmacol; 2007 Mar; 71(3):695-703. PubMed ID: 17158200
[TBL] [Abstract][Full Text] [Related]
6. A novel FGF2 antagonist peptide P8 with potent antiproliferation activity.
Fan L; Xie H; Chen L; Ye H; Ying S; Wang C; Wu X; Li W; Wu J; Liang G; Li X
Tumour Biol; 2014 Oct; 35(10):10571-9. PubMed ID: 25062723
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
8. Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells.
Zaragosi LE; Ailhaud G; Dani C
Stem Cells; 2006 Nov; 24(11):2412-9. PubMed ID: 16840552
[TBL] [Abstract][Full Text] [Related]
9. Effect of CCN2 on FGF2-induced proliferation and MMP9 and MMP13 productions by chondrocytes.
Nishida T; Kubota S; Aoyama E; Janune D; Maeda A; Takigawa M
Endocrinology; 2011 Nov; 152(11):4232-41. PubMed ID: 21914781
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells.
Kim MS; Kim CJ; Jung HS; Seo MR; Juhnn YS; Shin HY; Ahn HS; Thiele CJ; Chi JG
J Pathol; 2004 Jan; 202(1):103-12. PubMed ID: 14694527
[TBL] [Abstract][Full Text] [Related]
11. Site-Specific, Stoichiometric-Controlled, PEGylated Conjugates of Fibroblast Growth Factor 2 (FGF2) with Hydrophilic Auristatin Y for Highly Selective Killing of Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1 (FGFR1).
Krzyscik MA; Zakrzewska M; Otlewski J
Mol Pharm; 2020 Jul; 17(7):2734-2748. PubMed ID: 32501706
[TBL] [Abstract][Full Text] [Related]
12. A time-resolved live cell imaging assay to identify small molecule inhibitors of FGF2 signaling.
Ahmed M; Legrand C; Yagüe Relimpio A; Beretta CA; Muschko A; Wegehingel S; Müller HM; Sehr P; Will DW; Lewis JD; Nickel W
FEBS Lett; 2019 Aug; 593(16):2162-2176. PubMed ID: 31135968
[TBL] [Abstract][Full Text] [Related]
13. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
[TBL] [Abstract][Full Text] [Related]
14. Foscarnet reduces FGF2-induced proliferation of human umbilical vein endothelial cells and has antineoplastic activity against human anaplastic thyroid carcinoma cells.
Rose K
Biomed Pharmacother; 2013 Feb; 67(1):53-7. PubMed ID: 23228448
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
Presta M; Oreste P; Zoppetti G; Belleri M; Tanghetti E; Leali D; Urbinati C; Bugatti A; Ronca R; Nicoli S; Moroni E; Stabile H; Camozzi M; Hernandez GA; Mitola S; Dell'Era P; Rusnati M; Ribatti D
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):71-6. PubMed ID: 15514208
[TBL] [Abstract][Full Text] [Related]
16. Similar expression to FGF (Sef) reduces endometrial adenocarcinoma cells proliferation via inhibiting fibroblast growth factor 2-mediated MAPK/ERK signaling pathway.
Zhang H; Zhao X; Yan L; Li M
Gynecol Oncol; 2011 Sep; 122(3):669-74. PubMed ID: 21663947
[TBL] [Abstract][Full Text] [Related]
17. Tyrphostin AG1478 suppresses proliferation and invasion of human breast cancer cells.
Zhang YG; Du Q; Fang WG; Jin ML; Tian XX
Int J Oncol; 2008 Sep; 33(3):595-602. PubMed ID: 18695891
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 2 mRNA expression evoked by amitriptyline involves extracellular signal-regulated kinase-dependent early growth response 1 production in rat primary cultured astrocytes.
Kajitani N; Hisaoka-Nakashima K; Okada-Tsuchioka M; Hosoi M; Yokoe T; Morioka N; Nakata Y; Takebayashi M
J Neurochem; 2015 Oct; 135(1):27-37. PubMed ID: 26183033
[TBL] [Abstract][Full Text] [Related]
19. FGF signaling network in the gastrointestinal tract (review).
Katoh M; Katoh M
Int J Oncol; 2006 Jul; 29(1):163-8. PubMed ID: 16773196
[TBL] [Abstract][Full Text] [Related]
20. The role of exogenous/endogenous basic fibroblast growth factor (FGF2) and transforming growth factor beta (TGF beta-1) on human corneal endothelial cells proliferation in vitro.
Rieck P; Oliver L; Engelmann K; Fuhrmann G; Hartmann C; Courtois Y
Exp Cell Res; 1995 Sep; 220(1):36-46. PubMed ID: 7664841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
